Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.

指南 医学 感染控制 疾病控制 手术部位感染 咨询委员会 疾病预防 流行病学 家庭医学 医疗急救 重症监护医学 外科 环境卫生 病理 公共行政 政治学
作者
Alicia J. Mangram,Teresa Horan,Michele L. Pearson,Leah Christine Silver,William R. Jarvis
出处
期刊:PubMed 卷期号:27 (2): 97-4; discussion 96 被引量:2747
链接
标识
摘要

EXECUTIVE SUMMARY The "Guideline for Prevention of Surgical Site Infection, 1999" presents the Centers for Disease Control and Prevention (CDC)'s recommendations for the prevention of surgical site infections (SSIs), formerly called surgical wound infections. This two-part guideline updates and replaces previous guidelines.1,2 Part I, "Surgical Site Infection: An Overview," describes the epidemiology, definitions, microbiology, pathogenesis, and surveillance of SSIs. Included is a detailed discussion of the pre-, intra-, and postoperative issues relevant to SSI genesis. Part II, "Recommendations for Prevention of Surgical Site Infection," represents the consensus of the Hospital Infection Control Practices Advisory Committee (HICPAC) regarding strategies for the prevention of SSIs.3 Whenever possible, the recommendations in Part II are based on data from well-designed scientific studies. However, there are a limited number of studies that clearly validate risk factors and prevention measures for SSI. By necessity, available studies have often been conducted in narrowly defined patient populations or for specific kinds of operations, making generalization of their findings to all specialties and types of operations potentially problematic. This is especially true regarding the implementation of SSI prevention measures. Finally, some of the infection control practices routinely used by surgical teams cannot be rigorously studied for ethical or logistical reasons (e.g., wearing vs not wearing gloves). Thus, some of the recommendations in Part II are based on a strong theoretical rationale and suggestive evidence in the absence of confirmatory scientific knowledge.It has been estimated that approximately 75% of all operations in the United States will be performed in "ambulatory," "same-day," or "outpatient" operating rooms by the turn of the century.4 In recommending various SSI prevention methods, this document makes no distinction between surgical care delivered in such settings and that provided in conventional inpatient operating rooms. This document is primarily intended for use by surgeons, operating room nurses, postoperative inpatient and clinic nurses, infection control professionals, anesthesiologists, healthcare epidemiologists, and other personnel directly responsible for the prevention of nosocomial infections. This document does not: Specifically address issues unique to burns, trauma, transplant procedures, or transmission of bloodborne pathogens from healthcare worker to patient, nor does it specifically address details of SSI prevention in pediatric surgical practice. It has been recently shown in a multicenter study of pediatric surgical patients that characteristics related to the operations are more important than those related to the physiologic status of the patients.5 In general, all SSI prevention measures effective in adult surgical care are indicated in pediatric surgical care. Specifically address procedures performed outside of the operating room (e.g., endoscopic procedures), nor does it provide guidance for infection prevention for invasive procedures such as cardiac catheterization or interventional radiology. Nonetheless, it is likely that many SSI prevention strategies also could be applied or adapted to reduce infectious complications associated with these procedures. Specifically recommend SSI prevention methods unique to minimally invasive operations (i.e., laparoscopic surgery). Available SSI surveillance data indicate that laparoscopic operations generally have a lower or comparable SSI risk when contrasted to open operations.6-11 SSI prevention measures applicable in open operations (e.g., open cholecystectomy) are indicated for their laparoscopic counterparts (e.g., laparoscopic cholecystectomy). Recommend specific antiseptic agents for patient preoperative skin preparations or for healthcare worker hand/forearm antisepsis. Hospitals should choose from products recommended for these activitie

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Rita发布了新的文献求助10
刚刚
1秒前
zxq1996完成签到 ,获得积分10
2秒前
4秒前
skxxxxxx完成签到,获得积分10
4秒前
李彪发布了新的文献求助30
4秒前
4秒前
ff发布了新的文献求助10
5秒前
5秒前
科研通AI2S应助聪慧棒棒糖采纳,获得10
5秒前
宋丹丹发布了新的文献求助10
5秒前
5秒前
阿夸完成签到,获得积分10
6秒前
Yiling完成签到,获得积分10
7秒前
7秒前
隐形曼青应助李某某采纳,获得10
7秒前
8秒前
幸福大白发布了新的文献求助10
8秒前
英姑应助YGYANG采纳,获得10
8秒前
jefflin完成签到 ,获得积分20
8秒前
在水一方应助勤恳兔子采纳,获得10
9秒前
10秒前
榴莲发布了新的文献求助10
10秒前
过湘发布了新的文献求助10
10秒前
iii发布了新的文献求助10
10秒前
11秒前
ding应助12333采纳,获得10
12秒前
vvv发布了新的文献求助10
13秒前
ceixxxxx完成签到,获得积分20
14秒前
成就的迎夏完成签到,获得积分10
14秒前
14秒前
竹竹竹发布了新的文献求助10
15秒前
15秒前
15秒前
linxm发布了新的文献求助10
16秒前
怡宝1223发布了新的文献求助10
18秒前
852应助阿夸采纳,获得10
18秒前
19秒前
SunXinwei发布了新的文献求助10
19秒前
hqf完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Pediatric Injectable Drugs 500
Instant Bonding Epoxy Technology 500
Methodology for the Human Sciences 500
ASHP Injectable Drug Information 2025 Edition 400
DEALKOXYLATION OF β-CYANOPROPIONALDEYHDE DIMETHYL ACETAL 400
Assessment of adverse effects of Alzheimer's disease medications: Analysis of notifications to Regional Pharmacovigilance Centers in Northwest France 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4372025
求助须知:如何正确求助?哪些是违规求助? 3869374
关于积分的说明 12062380
捐赠科研通 3512125
什么是DOI,文献DOI怎么找? 1927238
邀请新用户注册赠送积分活动 969277
科研通“疑难数据库(出版商)”最低求助积分说明 868119